DE LEO, SIMONE

DE LEO, SIMONE  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
ASO Author Reflections: Total Thyroidectomy Versus Lobectomy for Differentiated Thyroid Cancer 1-gen-2021 Colombo C.De Leo S.Fugazzola L. Article (author) -
Autoimmune thyroid disease during pregnancy 1-gen-2017 De Leo, Simone + Article (author) -
Can preoperative 25-hydroxyvitamin D levels predict transient hypocalcemia after total thyroidectomy? 1-gen-2021 Saibene, Alberto MariaRosso, CeciliaFelisati, GiovanniPipolo, CarlottaDe Leo, SimoneCozzolino, Mario Gennaro + Article (author) -
Fetal cell microchimerism in papillary thyroid cancer : a role in the outcome of the disease 1-gen-2015 V. CirelloC. ColomboS. De LeoM. MuzzaM.A. MaffiniL. Fugazzola + Article (author) -
Il carcinoma della tiroide nell’anziano: terapia e follow-up 1-lug-2021 Colombo, CarlaDe Leo, SimoneFugazzola, Laura Article (author) -
Impact of estrogen and progesterone receptors expression on the clinical and molecular features of papillary thyroid cancer 1-lug-2015 G. VannucchiS. De LeoD. TosiV. CirelloC. ColomboG. BulfamanteL. Fugazzola + Article (author) -
Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability 1-feb-2019 Colombo, CarlaMuzza, MarinaProverbio, Maria CarlaTosi, DelfinaPesenti, ChiaraRossi, StefaniaCirello, ValentinaDe Leo, SimoneFusco, NicolaMiozzo, MonicaBulfamante, GaetanoFerrero, StefanoTabano, SilviaFugazzola, Laura + Article (author) -
Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization 1-feb-2014 L. BenagliaA. BusnelliE. SomiglianaM. LeonardiG. VannucchiS. De LeoL. FugazzolaL. Fedele + Article (author) -
The optimal range of RET mutations to be tested : European comments to the guidelines of the American Thyroid Association 1-gen-2013 L. FugazzolaS. De LeoM. Perrino Article (author) -
Post-surgical ablative or adjuvant radioiodine therapy has no impact on outcome in 1–4 cm differentiated thyroid cancers without extrathyroidal extension 1-set-2021 De Leo S.Trevisan M.Colombo C.Persani L.Fugazzola L. + Article (author) -
Primary Adrenal Insufficiency during Lenvatinib or Vandetanib and Improvement of Fatigue after Cortisone Acetate Therapy 28-dic-2018 Colombo CDe Leo SDi Stefano MVannucchi GPersani LFugazzola L. Article (author) -
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 1-ago-2014 A.S. TresoldiL.F. SburlatiM. PerrinoS. De LeoL. MontefuscoM. ArosioA.G.A. LaniaL. Fugazzola + Article (author) -
Refining calcium test for the diagnosis of medullary thyroid cancer : cutoffs, procedures, and safety 1-mag-2014 M. PerrinoC. ColomboS. FerreroS. De LeoC. CacciatoreL. PersaniL. Fugazzola + Article (author) -
Telomerase in differentiated thyroid cancer : promoter mutations, expression and localization 1-gen-2015 M. MuzzaC. ColomboD. TosiV. CirelloS. De LeoG. BulfamanteL. Fugazzola + Article (author) -
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review 1-ago-2021 Carla ColomboSimone De LeoMarta Di StefanoMatteo TrevisanLaura Fugazzola + Article (author) -
Ultrasound-guided percutaneous ethanol injection in papillary thyroid cancer metastatic lymph-nodes 1-gen-2014 S. De LeoL. Fugazzola + Article (author) -